CAS: 183619-38-7 - 4-Acetamido-N-(tert-butyl)benzamide
Formula:C13H18N2O2
InChI:InChI=1/C13H18N2O2/c1-9(16)14-11-7-5-10(6-8-11)12(17)15-13(2,3)4/h5-8H,1-4H3,(H,14,16)(H,15,17)
- Synonyms:
- Ren-1189
- Cpi-1189
- 4-(acetylamino)-N-tert-butylbenzamide
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CPI-1189 REF: IN-DA00AS51CAS: 183619-38-7 | 98% | To inquire | Tue 21 Jan 25 |
 | 4-Acetamido-N-(tert-butyl)benzamide REF: 10-F981175CAS: 183619-38-7 | 97% | 166.00 €~260.00 € | Thu 23 Jan 25 |
 | CPI1189 REF: TM-T3561CAS: 183619-38-7 | 98.87% - 99.68% | 37.00 €~820.00 € | Mon 27 Jan 25 |
 | CPI-1189 REF: 3D-IHA61938CAS: 183619-38-7 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA00AS51
| 1g | 103.00 € | ||
| 25mg | 28.00 € | ||
| 100mg | 35.00 € | ||
| 250mg | 52.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Ref: 10-F981175
| 100mg | 166.00 € | ||
| 250mg | 260.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
CPI1189
CAS:183619-38-7
CPI1189 (REN-1189) is a TNF-a release inhibitor potentially for the treatment of sciatica and postherpetic …
Formula:
C13H18N2O2
Purity:
98.87% - 99.68%
Color and Shape:
Solid
Molecular weight:
234.29
Ref: TM-T3561
| 10mg | 46.00 € | ||
| 25mg | 93.00 € | ||
| 50mg | 137.00 € | ||
| 100mg | 219.00 € | ||
| 200mg | 305.00 € | ||
| 1mL*10mM (DMSO) | 37.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
CPI-1189
CAS:183619-38-7
CPI-1189 is a novel, potent and selective inhibitor of TNF-α. In vitro studies have shown …
Formula:
C13H18N2O2
Purity:
Min. 95%
Molecular weight:
234.29 g/mol
Ref: 3D-IHA61938
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
